Surgery Partners (SGRY) Shares Outstanding (Weighted Average) (2013 - 2026)

Surgery Partners has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $128.4 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $128.4 million, up 1.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $128.4 million (up 1.39% YoY), and the FY2025 annual result was $127.2 million, up 0.86% from the prior year.
• Shares Outstanding (Weighted Average) came in at $128.4 million for Q1 2026 at Surgery Partners, up from $127.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $128.4 million in Q1 2026 to a low of $88.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $126.0 million (2024), against an average of $117.6 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 60.65% in 2022 and grew 0.41% in 2024, its largest moves.
• Surgery Partners' Shares Outstanding (Weighted Average) stood at $92.0 million in 2022, then surged by 36.61% to $125.6 million in 2023, then increased by 0.41% to $126.1 million in 2024, then grew by 0.86% to $127.2 million in 2025, then advanced by 0.91% to $128.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $128.4 million (Q1 2026), $127.2 million (Q4 2025), and $127.2 million (Q3 2025), per Business Quant data.